Literature DB >> 32278042

Natural and synthetic compounds as dissociated agonists of glucocorticoid receptor.

Tiehua Zhang1, Yuan Liang1, Jie Zhang2.   

Abstract

Glucocorticoid receptor (GR) belongs to the superfamily of steroid hormone receptors. The dissociated or selective GR modulators (SEGRMs), preferring the transrepression rather than the transactivation, might exhibit anti-inflammatory activities with fewer side effects. This work presents a review of the molecular mechanism of GR involved in regulation of inflammation. As complementary or alternative therapeutic agents, the botanical compounds have been extensively used in the treatment of various diseases. Hence, this work reviews the botanical compounds as well as the synthetic compounds currently known to be potential SEGRMs. High-throughput virtual screening of SEGRMs from natural products has also been summarized.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dissociated characteristics; Natural products; Selective glucocorticoid receptor modulators; Transactivation; Transrepression

Mesh:

Substances:

Year:  2020        PMID: 32278042     DOI: 10.1016/j.phrs.2020.104802

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  7 in total

Review 1.  Herbal compounds in the treatment of pulmonary silicosis.

Authors:  J Adamcakova; D Mokra
Journal:  Physiol Res       Date:  2021-12-31       Impact factor: 1.881

2.  Deacylcortivazol-like pyrazole regioisomers reveal a more accommodating expanded binding pocket for the glucocorticoid receptor.

Authors:  Jessica A O Zimmerman; Mimi Fang; Bintou Doumbia; Alexis Neyman; Ji Hyeon Cha; Michael Thomas; Bonnie Hall; Meng Wu; Anne M Wilson; Miles A Pufall
Journal:  RSC Med Chem       Date:  2020-12-08

3.  Identification of dicyclohexyl phthalate as a glucocorticoid receptor antagonist by molecular docking and multiple in vitro methods.

Authors:  Yue Leng; Yonghai Sun; Wei Huang; Chengyu Lv; Jingyan Cui; Tiezhu Li; Yongjun Wang
Journal:  Mol Biol Rep       Date:  2021-04-21       Impact factor: 2.316

4.  Differential off-target glucocorticoid activity of progestins used in endocrine therapy.

Authors:  Maleshigo Komane; Chanel Avenant; Renate Louw-du Toit; Donita J Africander; Janet P Hapgood
Journal:  Steroids       Date:  2022-03-07       Impact factor: 2.760

5.  Discovery of Novel GR Ligands toward Druggable GR Antagonist Conformations Identified by MD Simulations and Markov State Model Analysis.

Authors:  Xueping Hu; Jinping Pang; Jintu Zhang; Chao Shen; Xin Chai; Ercheng Wang; Haiyi Chen; Xuwen Wang; Mojie Duan; Weitao Fu; Lei Xu; Yu Kang; Dan Li; Hongguang Xia; Tingjun Hou
Journal:  Adv Sci (Weinh)       Date:  2021-11-26       Impact factor: 16.806

Review 6.  The long winding road to the safer glucocorticoid receptor (GR) targeting therapies.

Authors:  Ekaterina A Lesovaya; Daria Chudakova; Gleb Baida; Ekaterina M Zhidkova; Kirill I Kirsanov; Marianna G Yakubovskaya; Irina V Budunova
Journal:  Oncotarget       Date:  2022-02-18

7.  Identification of 20(S)-Ginsenoside Rh2 as a Potential EGFR Tyrosine Kinase Inhibitor.

Authors:  Yuan Liang; Jingqi Zhao; Haoyang Zou; Jie Zhang; Tiehua Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-01-24       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.